Looking Back, I Realize That

But The Prospects Of Designing Chemical Plants For Industrial Scale Chemical Processes Seemed Far Less Interesting Than The Chemical Events That Occur In Biological Systems.

By Then, I Was Making The Slow Transition From Classical Biochemistry To Molecular Biology And Becoming Increasingly Preoccupied With How Genes Act And How Proteins Are Made.

Paradoxically, No Such Embargo Exists For The Drugs And Therapies That Have Revolutionized The Treatment Of Serious Diseases Although Many Of Them Were Created With The Same Technologies.

Fears Of Creating New Kinds Of Plagues Or Of Altering Human Evolution Or Of Irreversibly Altering The Environment Were Only Some Of The Concerns That Were Rampant.

Today, It Is Research With Human Embryonic Stem Cells And Attempts To Prepare Cloned Stem Cells For Research And Medical Therapies That Are Being Disavowed As Being Ethically Unacceptable.